Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Alibaba Unveils NextGeneration Zhenwu AI Chip and Large Language Model to Bolster Cloud AI Portfolio Nationwide Faces Governance Concerns as Labour MP Raises Issues Before AGM Explosion on Passenger Train in Quetta Injures Over 30 Security Concerns May Impact Pakistans Investment Climate Beyond Inc Acquires Buy Buy Baby Brand Rights Plans Reunification with Bed Bath Beyond IndustryEducation Collaboration Reshapes New Hampshires Advanced Manufacturing Landscape Primoris Services Corporation Q1 2026 Earnings EPS Misses Estimates by 315 Stock Rises Despite Disappointment AGCO Q1 2026 Earnings Strong Profit Beat Bolsters Investor Sentiment After Challenging Quarter BHFAL Q1 2026 Earnings Earnings Miss Estimates Amid Market Challenges CTOR Q1 2026 Earnings Deep Losses and Negative Surprise as Company Remains PreRevenue PTGX Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency DVLT Q1 2026 Earnings WiderthanExpected Loss Amid Strategic Progress Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume Lionheart Holdings Warrant CUBWW Surges 27 as Price Tests Key Resistance Spire Inc SR Edges Higher as Stock Holds Above Key Support Levels MBINL Preferred Shares Edge Higher as Income Investors Seek Stability Lee Enterprises LEE Surges 34 as Stock Tests Key Resistance Level Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday THO Q1 2026 Earnings Massive EPS Beat Drives Positive Market Response Serina Therapeutics Inc SER Recovers 493 as Stock Approaches Key Resistance at 208 Lionheart Holdings CUB Consolidates at 1080 Key Levels Define the Next Move PMV Pharmaceuticals PMVP Slips to 126 as Cautious Trading Puts Support to the Test XMAX Inc XWIN Holds Steady at 824 as Traders Eye Key Resistance Level Asia Pacific Wire Cable APWC Holds Steady at 150 as Consolidation Continues Nutanix NTNX Slips 126 as Shares Approach Critical Support Near 44 Nutanix NTNX Faces Resistance as Shares Edge Lower Amidst Volume Patterns Cellectar Biosciences CLRB Posts Modest Gains as Shares Consolidate Near Resistance